Next Generation Feasibility Webinar To Highlight Innovations That Improve Clinical Trial Feasiblity And Reduce Trial Timelines

BURLINGTON, Mass., April 1, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials efficiently and predictably, will discuss the latest innovations in trial feasibility during a webinar next week hosted by Clinical Informatics News.

Otis Johnson, executive director of feasibility and clinical informatics at iCTRS, will discuss approaches to leveraging data and analytics, as well as internal and external expertise to gather protocol and investigator intelligence prior to engaging sites. Leveraging innovation in the form of advanced technologies streamlines site selection and reduces the timelines associated with site feasibility to get a trial off on the right foot.

"The goal is to identify, qualify and enroll the highest performing investigators more quickly and effectively than ever before," Johnson said.  "But the ultimate goal is getting drugs into development and then into the marketplace faster for optimized revenue and for patients who need better treatment."

The webinar at 1 p.m. EDT on April 8^th is designed to teach attendees innovative approaches for feasibility analysis, better integration of data sources for more informed decisions and how to increase predictability in study enrollment timeframes through efficient site selection.

Johnson said that for many years, biopharmaceutical companies have made false assumptions on how long it takes to enroll a trial, how many sites are needed, in which countries they are needed and how many patients to enroll per site. The biggest mistake, he said, was counting on investigators themselves to produce all the required patients from their own practices.  

According to Gartner, missing enrollment timelines cost clinical trial sponsors $37,000 a day in unexpected operational costs and much more in opportunity costs. To help address the problem, iCTRS has amassed a proprietary combination of global data on patients, investigators, sites and trials, as well as a novel set of analytical tools to gain insights from the data.

How this is done and to what effect will be the basis for much of Johnson's presentation.

For more information on how to register for the Next Generation Feasibility Analysis webinar, visit:  http://www.clinicalinformaticsnews.com/ecliniqua_webinar.aspx?id=135550.

About inVentiv Health
inVentiv Health, Inc. is a life science knowledge and services company purpose-built for the new healthcare marketplace. inVentiv has created a new model by converging a vast range of essential services to fully align with our client's development and commercialization goals. With more than 12,000 employees supporting clients in 70 countries, our global scale and broad expertise make us an attractive strategic partner for companies seeking to get medicines to patients in a complex operating, regulatory and reimbursement environment.  inVentiv Health's clients include more than 550 life sciences companies, including all 20 of the largest biopharmaceutical companies in the world. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. inVentiv Health transforms promising ideas into commercial reality for the financial success of our clients and the delivery of better treatments to patients worldwide. For more information, visit www.inVentivHealth.com.

About Clinical Informatics News
Clinical Informatics News reports on innovative technologies from clinical trials to medical informatics. Technology continues to permeate all aspects of clinical trials and the patient experience, and the tools to support these efforts are maturing rapidly. ClinicalInformaticsNews.com and the Clinical Informatics News email newsletter provide authoritative news, views, and insights on the vast landscape of innovation between clinical trial management and delivery of care.

SOURCE inVentiv Health, Inc.